ESMC — Escalon Medical Income Statement
0.000.00%
Last trade - 00:00- $1.14m
- $1.51m
- $12.05m
- 77
- 91
- 25
- 71
Annual income statement for Escalon Medical, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10.5 | 10.7 | 12.2 | 12 | 12 |
| Cost of Revenue | |||||
| Gross Profit | 4.43 | 4.61 | 5.48 | 5.15 | 5.51 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 10.5 | 11.2 | 11.7 | 12.1 | 11.9 |
| Operating Profit | -0.034 | -0.47 | 0.479 | -0.104 | 0.133 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.052 | 0.018 | 0.457 | -0.125 | 0.106 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.052 | 0.018 | 0.457 | -0.125 | 0.106 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.052 | 0.018 | 0.457 | -0.125 | 0.106 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.103 | -0.034 | 0.222 | -0.177 | 0.028 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.014 | -0.005 | 0.03 | -0.024 | 0.002 |